Multi-omics in high-grade serous ovarian cancer: Biomarkers from genome to the immunome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multi-omics in high-grade serous ovarian cancer: Biomarkers from genome to the immunome

Published:2018-05-21 Issue:2 Volume:80 Page:e12975
ISSN:1046-7408
Container-title:American Journal of Reproductive Immunology
language:en
Short-container-title:Am J Reprod Immunol

Author:

Clifford Cole¹,Vitkin Natasha¹²,Nersesian Sarah¹²,Reid-Schachter Gillian¹,Francis Julie-Ann³,Koti Madhuri¹²³^ORCID

Affiliation:

1. Department of Biomedical and Molecular Sciences; Queen's University; Kingston ON Canada

2. Cancer Biology and Genetics; Queen's Cancer Research Institute; Queen's University; Kingston ON Canada

3. Department of Obstetrics and Gynecology; Kingston Health Sciences Center; Queen's University; Kingston ON Canada

Funder

Nancy Sutherland Ovarian Cancer Fund

Publisher

Wiley

Subject

Obstetrics and Gynaecology,Reproductive Medicine,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/aji.12975/fullpdf

Reference86 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

2. A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer;Koti;Br J Cancer,2015

3. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer;Bowtell;Nat Rev Cancer,2015

4. Ovarian cancer;Jayson;Lancet,2014

5. Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer;Leffers;Cancer Immunol Immunother,2009

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment;Frontiers in Drug Delivery;2024-02-01

2. Globally shared TCR repertoires within the tumor-infiltrating lymphocytes of patients with metastatic gynecologic cancer;Scientific Reports;2023-11-22

3. In vivo Safety and Immunoactivity of Oncolytic Jurona Virus in Hepatocellular Carcinoma: A Comprehensive Proteogenomic Analysis;2022-09-13

4. Toward improvement of screening through mass spectrometry-based proteomics: Ovarian cancer as a case study;International Journal of Mass Spectrometry;2021-11

5. Engineering strategies for broad application of TCR-T- and CAR-T-cell therapies;International Immunology;2021-08-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3